Surgeons: Chad LaGrange, MD and Matthew Tollefson, MD

Moderator: Khurshid Guru, MD

Discussant: Alvin Goh, MD


Chad LaGrange, MD

Dr. Chad LaGrange FACS completed his urology residency and 2 year endourology fellowship at the University of Kentucky.  He then joined the faculty at the University of Nebraska Medical Center in 2008 as an assistant professor.  He has progressed to the role of Edward and Sally Malashock Endowed Chair of Urology, professor, and chief of Urology.  He previously served as the urology residency program director and has served on the Board of Directors for the South Central Section of the American Urological Association.  He has received several teaching awards as well as the Young Urologist of the Year from the SCSAUA.  His clinical interests include robotic surgery, percutaneous nephrolithotomy, and oncology.

Matthew Tollefson, MD

Associate Professor of Urology, Mayo Clinic College of Medicine

Matthew Tollefson, M.D., is a Consultant in the Department of Urology at Mayo Clinic as well as Associate Professor of Urology at Mayo Clinic College of Medicine in Rochester, Minnesota. Dr. Tollefson is a Minnesota native having graduated from Saint Olaf College prior to his arrival at the Mayo Clinic where he completed his residency and a fellowship in Urologic Oncology in the Department of Urology at Mayo Clinic, Rochester, Minnesota.

Dr. Tollefson has authored and co-authored many scientific publications at both the national and international levels. He has been an invited speaker locally, nationally, and internationally regarding robotic surgery. Dr. Tollefson is a reviewer to several journals including Journal of Urology, European Urology, Cancer and the Journal of Clinical Oncology. He currently chairs the Robotics Surgical Committee at the Mayo Clinic.

Khurshid Guru, MD

Khurshid A. Guru, MD, was appointed Director of Robotic Surgery at Roswell Park Cancer Institute (RPCI) in October 2005 and Chair, Department of Urology in June 2017. Dr. Guru completed his residency training in Urologic Surgery (2005) and a Robotic Surgery Fellowship (2004), Henry Ford Health System, MI. He also completed an International Fellowship in Urologic-Oncology (2004) at the Urology and Nephrology Center at Mansoura University, Mansoura, Egypt.

Dr. Guru is one of the early fellowship-trained robotic surgeons (2004) with an experience of over 10,000 surgical console hours and has performed over 2,500 procedures. Dr. Guru performed one of the first robot-assisted radical cystectomy in the world, and has worked in development and evolution of oncologic safety and efficacy of minimally invasive approaches to bladder cancer. Dr. Guru has performed live demonstrations of robotic surgery in eleven countries at international seminars. His experience in robot-assisted surgery, especially his 600 robot-assisted radical cystectomies, has been shared with over 400 surgeons from more than 15 countries.

His research interest has also been in the application of robotic surgery for urinary reconstruction. Dr. Guru developed one of the first robotic surgical simulators and works extensively in safe human machine interface, cognitive interaction and developing safe environments during robot-assisted surgery. Dr. Guru developed the first validated robotic surgery curriculum for safe transfer of surgical skills for future robotic surgeons. His major interest is bladder cancer and robotic surgical education and its incorporation. He leads the International Robotic Cystectomy Consortium with over 55 surgeon members in over 23 countries. He also leads the Applied Technology Laboratory for Advanced Surgery (ATLAS) Program at RPCI.

Dr. Guru is a member of the American Urological Association, Cancer Society of Kashmir. He founded a non-profit foundation in 2007 which supports health and education related programs in Kashmir. His foundation supports children in government run schools in his native home, Kashmir.

He has authored and co-authored over 250 several journal articles, abstracts and book chapters.

Alvin Goh, MD

Dr. Goh is a fellowship-trained urologist specializing in minimally invasive surgical treatments, including robotic, laparoscopic, and endourologic procedures, for general and complex urologic oncologic diseases. He has particular expertise in bladder, prostate, and kidney cancer as well as adrenal masses, and urinary tract reconstruction. He is Director of Robotic Urologic Surgery Technology and Education at Memorial Sloan Kettering Cancer Center.

Dr. Goh received his medical degree from Northwestern University and completed his general surgery internship and urology residency at the Baylor College of Medicine. He pursued sub-specialty fellowship training in advanced laparoscopy and robotic surgery at the University of Southern California.

Dr. Goh has helped to develop novel techniques for robotic bladder cancer surgery and intracorporeal urinary reconstruction, robotic kidney-sparing surgery, and single-site robotic and laparoscopic surgery. He has won multiple awards for his scientific presentations and surgical videos at national and international meetings. His research focuses on the application of new technology in the treatment of urologic diseases.